Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
21.78
+0.74 (3.52%)
At close: Jun 26, 2026, 4:00 PM EDT
21.78
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Amphastar Pharmaceuticals stock have an average target of 21.4, with a low estimate of 19 and a high estimate of 25. The average target predicts a decrease of -1.74% from the current stock price of 21.78.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 4 | 4 | 4 | 5 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Reiterates $23 → $20 | Hold | Reiterates | $23 → $20 | -8.17% | Jun 3, 2026 |
| Wells Fargo | Wells Fargo | Hold Downgrades $30 → $19 | Hold | Downgrades | $30 → $19 | -12.76% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $25 → $21 | Hold | Maintains | $25 → $21 | -3.58% | May 11, 2026 |
| Needham | Needham | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $28 → $25 | Hold | Reiterates | $28 → $25 | +14.78% | May 8, 2026 |
Financial Forecast
Revenue This Year
746.79M
from 719.89M
Increased by 3.74%
Revenue Next Year
788.44M
from 746.79M
Increased by 5.58%
EPS This Year
2.68
from 3.25
Decreased by -17.53%
EPS Next Year
3.14
from 2.68
Increased by 17.24%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 759.3M | 817.0M | |
| Avg | 746.8M | 788.4M | |
| Low | 730.6M | 752.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.5% | 9.4% | |
| Avg | 3.7% | 5.6% | |
| Low | 1.5% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | 2.68 | 3.14 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -17.5% | 17.2% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.